Paul Fawcett, PhD

Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia; JBMR Plus; (2023).

Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate; Pediatrics; (2019).

Inflammatory Response of Pulmonary Artery Smooth Muscle Cells Exposed to Oxidative and Biophysical Stress; Inflammation; (2018).

The role of transforming growth factor β signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: Dysregulation of transforming growth factor β signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy; Arthritis and Rheumatology; (2014).

Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo; BMC Cancer; (2011).

Prolonged synovitis in pediatric lyme arthritis cannot be predicted by clinical or laboratory parameters; Clinical Rheumatology; (2009).

Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection; Clinical and Experimental Rheumatology; (2008).

Cytokine load in prestorage leukoreduced PRBC transfusions in premature infants; Journal of Perinatology; (2005).

Comparison of PCR and clinical laboratory tests for diagnosing H. pylori infection in pediatric patients; BMC Microbiology; (2004).

Long-term effects of immunization with recombinant lipoprotein outer surface protein A on serologic test for Lyme disease; Clinical and Diagnostic Laboratory Immunology; (2004).

C<inf>6</inf> Test as an Indicator of Therapy Outcome for Patients with Localized or Disseminated Lyme Borreliosis; Journal of Clinical Microbiology; (2003).

Growth of Helicobacter pylori in a long spiral form does not alterexpression of immunodominant proteins; BMC Microbiology; (2002).

In vitro assessment of antiborrelial activity of OspA vaccine sera; Clinical and Diagnostic Laboratory Immunology; (2002).

Arthritis following recombinant outer surface protein A vaccination for lyme disease; Journal of Rheumatology; (2001).

Antibody response to IR<inf>6</inf>, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans; Journal of Infectious Diseases; (2001).

Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis; Clinical and Diagnostic Laboratory Immunology; (2001).

Helicobacter pylori can be induced to assume the morphology of Helicobacter heilmannii; Journal of Clinical Microbiology; (1999).

Use of ELISA to measure antinuclear antibodies in children with juvenile rheumatoid arthritis; Journal of Rheumatology; (1999).

Comparison of immunodot and Western blot assays for diagnosing Lyme borreliosis; Clinical and Diagnostic Laboratory Immunology; (1998).

Correlation of seroreactivity with response to antibiotics in pediatric Lyme borreliosis; Clinical and Diagnostic Laboratory Immunology; (1997).

Residual serologic reactivity in children with resolved Lyme arthritis; Journal of Rheumatology; (1996).

Usefulness of soluble interleukin-2 receptor specificity [9]; Journal of Pediatrics; (1996).

Pharmacokinetics of teratogenic antibodies administered to rats; Teratology; (1995).

Comparative evaluation of adsorption with E. coli on ELISA tests for Lyme borreliosis; Journal of Rheumatology; (1995).

Soluble interleukin-2 receptor as a predictor of neonatal sepsis; The Journal of Pediatrics; (1995).

The Overdiagnosis of Lyme Disease in Children Residing in an Endemic Area; Clinical Pediatrics; (1994).

Pediatric Lyme Arthritis: Clinical Spectrum And Outcome; Journal of Pediatric Orthopaedics; (1994).

Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate; Annals of the Rheumatic Diseases; (1994).

Reinfection in paediatric Lyme borreliosis [2]; Annals of the Rheumatic Diseases; (1993).

Detection of antibodies to the recombinant P39 protein of Borrelia burgdorferi using enzyme immunoassay and immunoblotting; Journal of Rheumatology; (1993).

Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease; Journal of Pediatric Gastroenterology and Nutrition; (1993).

Serial measurement of soluble interleukin 2 receptor levels: An early indicator of treatment response for Lyme disease; Journal of Rheumatology; (1993).

Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens; Journal of Rheumatology; (1992).

Soluble interleukin‐2 receptor levels in infants with bronchopulmonary dysplasia; Pediatric Pulmonology; (1992).

Lyme neuroborreliosis: A potential cause of median neuropathy in a child and young adult; Infectious Diseases in Clinical Practice; (1992).

Use of Western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease; Pediatrics; (1991).

Adsorption with a soluble E. coli antigen fraction improves the specificity of ELISA tests for Lyme disease; Journal of Rheumatology; (1991).

Induction of humoral manifestations of autoimmunity following intraperitoneal injection of complete freund's adjuvant in mice; Autoimmunity; (1990).

Suppression of malaria-induced autoimmunity by immunization with cryoglobulins; Cellular Immunology; (1989).

GLOVE POWDER AND HIV ELISA TESTS; The Lancet; (1989).

An adsorption procedure to increase the specificity of enzyme‐linked immunosorbent assays for lyme disease without decreasing sensitivity; Arthritis &amp; Rheumatism; (1989).

Androgen Suppression of Circulating Immune Complexes and Enhanced Survival in Murine Malaria; Proceedings of the Society for Experimental Biology and Medicine; (1982).